Loading company…
Vancouver-based developer of NanoAssemblr nanomedicine tools for delivering nucleic acids and drugs to cells and tissues.
Precision NanoSystems provides medical tools and processes for medicines and medical research. Its NanoAssemblr platform makes nanoparticle formulations for delivering genetic material, drug molecules and diagnostic agents to cells and tissues. Founded in 2010 in Vancouver, Canada, the company was co-founded by James Taylor, Ph.D., as CEO and Euan Ramsay, Ph.D., as Chief Commercial Officer, and is at Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in